Literature DB >> 12297355

Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.

James A Karlowsky1, Deborah C Draghi, Clyde Thornsberry, Mark E Jones, Ian A Critchley, Daniel F Sahm.   

Abstract

Antimicrobial susceptibilities of clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were determined in two consecutive respiratory seasons in the US and suggested that national susceptibilities to commonly tested antimicrobials changed only slightly from the 1999-2000 to the 2000-2001 respiratory season. However, a significant regional variation in S. pneumoniae susceptibilities was observed, as was a decrease in beta-lactamase rates among H. influenzae from the 1999-2000 to 2000-2001 respiratory seasons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297355     DOI: 10.1016/s0924-8579(02)00124-3

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  4 in total

Review 1.  In vitro antibacterial activity and pharmacodynamics of new quinolones.

Authors:  A Dalhoff; F-J Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-04-01       Impact factor: 3.267

2.  Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.

Authors:  Kris P Heilmann; Cassie L Rice; Ashley L Miller; Norma J Miller; Susan E Beekmann; Michael A Pfaller; Sandra S Richter; Gary V Doern
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 3.  Acute rhinosinusitis in adults: an update on current management.

Authors:  Ajmal Masood; Ioannis Moumoulidis; Jaan Panesar
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

4.  National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study.

Authors:  Ian A Critchley; Steven D Brown; Maria M Traczewski; Glenn S Tillotson; Nebojsa Janjic
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.